Skip to content
Recall Observatory FDA recall evidence

Drug product

Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, NDC# 0641-6044-25

D-0551-2025

July 22, 2025

Class II

Product summary

Firm
Hikma Pharmaceuticals USA Inc.
Event
Event 97294
Status
Ongoing
Classification
Class II
Quantity
382,775 1mL vials
Official record key
drug-enforcement:D-0551-2025

Official wording

Reason: Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds

Code information: Lot # K24118, exp. date 10/31/2026

Distribution pattern: Distributed Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out-of-Specification